Christopher A. Marlett

Christopher A. Marlett has filed trades across 3 companies (mainly through SEC (Form 4)), most often in MDB Capital Holdings, LLC, Cue Biopharma, Inc. and Paradium.AI, Inc. In total, 68 filings cover trades dated from 21 October 2014 to 15 October 2026.

Market trades split into 52 purchases (€751k) and 7 sales (€1.3M). Netting one side against the other leaves €532k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants and 1 option exercise. In 2026 alone, the filings show 3 purchases and no sales.

The median purchase comes to €4,990. 13 out of 52 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 16 purchases show a median change of -7.5%, with the price up in 13% of them. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 16 October 2026 with an open-market purchase (€1,578) in MDB Capital Holdings, LLC. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.